INFU icon

InfuSystem Holdings

5.65 USD
+0.08
1.44%
At close Mar 12, 4:00 PM EDT
After hours
5.69
+0.04
0.71%
1 day
1.44%
5 days
-8.13%
1 month
-29.64%
3 months
-37.15%
6 months
-12.67%
Year to date
-30.07%
1 year
-38.18%
5 years
-16.91%
10 years
118.99%
 

About: InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.

Employees: 516

0
Funds holding %
of 7,363 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

48% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 21

29% more capital invested

Capital invested by funds: $92.8M [Q3] → $119M (+$26.6M) [Q4]

10% more funds holding

Funds holding: 78 [Q3] → 86 (+8) [Q4]

1.39% more ownership

Funds ownership: 64.95% [Q3] → 66.34% (+1.39%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

77% less call options, than puts

Call options by funds: $68K | Put options by funds: $291K

Research analyst outlook

We haven’t received any recent analyst ratings for INFU.

Financial journalist opinion

Based on 5 articles about INFU published over the past 30 days

Neutral
Seeking Alpha
1 week ago
InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU ) Q4 2024 Results Conference Call March 4, 2025 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Kyle Bauser - B. Riley Securities Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings Inc. Reports Fourth Quarter and Full Year 2024 Financial Results Conference Call.
InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call Transcript
Negative
Zacks Investment Research
1 week ago
InfuSystems Holdings, Inc. (INFU) Misses Q4 Earnings and Revenue Estimates
InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to break-even earnings per share a year ago.
InfuSystems Holdings, Inc. (INFU) Misses Q4 Earnings and Revenue Estimates
Neutral
Business Wire
1 week ago
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024.
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024
Neutral
Business Wire
2 weeks ago
InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025.
InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Positive
Seeking Alpha
4 weeks ago
InfuSystem Set For Strong Year
InfuSystem Holdings achieved 11% YoY revenue growth and expanded EBITDA margins by 2.8 percentage points in 3Q24. INFU's business plan focuses on high ROI revenue and less capital-intensive growth through partnerships, leading to higher margins and cash flows. Near-term growth drivers include agreements with Smith+Nephew, SMTI, and Dignitana, expected to boost FY25 revenue and margin expansion.
InfuSystem Set For Strong Year
Neutral
Business Wire
3 months ago
InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024.
InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024
Neutral
Business Wire
3 months ago
InfuSystem Appoints Ronald Hundzinski to the Board of Directors
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Appoints Ronald Hundzinski to the Board of Directors.
InfuSystem Appoints Ronald Hundzinski to the Board of Directors
Neutral
Seeking Alpha
4 months ago
InfuSystem Holdings, Inc. (INFU) Q3 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU ) Q3 2024 Results Conference Call November 7, 2024 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Jim Sidoti - Sidoti & Company Brooks O'Neil - Lake Street Capital Markets Kyle Bauser - B. Riley Securities Matt Hewitt - Craig-Hallum Capital Group Aaron Warwick - Breakout Investors Operator Good day, and welcome to the InfuSystem Third Quarter of 2024 Financial Results Conference Call.
InfuSystem Holdings, Inc. (INFU) Q3 2024 Earnings Call Transcript
Neutral
Business Wire
4 months ago
InfuSystem Reports Third Quarter 2024 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports Third Quarter 2024 Financial Results.
InfuSystem Reports Third Quarter 2024 Financial Results
Neutral
Business Wire
4 months ago
InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024.
InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
Charts implemented using Lightweight Charts™